5‐Fluorouracil efficacy requires anti‐tumor immunity triggered by cancer‐cell‐intrinsic STING-Reference-Cited by-同舟云学术

5‐Fluorouracil efficacy requires anti‐tumor immunity triggered by cancer‐cell‐intrinsic STING

Published:2021-02-22 Issue:7 Volume:40 Page:
ISSN:0261-4189
Container-title:The EMBO Journal
language:en
Short-container-title:EMBO J

Author:

Tian Jingru¹²³,Zhang Dingyao²³^ORCID,Kurbatov Vadim²⁴⁵,Wang Qinrong²³,Wang Yadong²³,Fang Dorthy⁶,Wu Lizhen⁷,Bosenberg Marcus⁴,Muzumdar Mandar D³⁴⁸,Khan Sajid⁴⁵,Lu Qianjin¹⁹,Yan Qin⁴⁷^ORCID,Lu Jun²³⁴¹⁰¹¹^ORCID

Affiliation:

1. Department of Dermatology Hunan Key Laboratory of Medical Epigenomics The Second Xiangya Hospital Central South University Changsha China

2. Yale Stem Cell Center New Haven CT USA

3. Department of Genetics Yale University School of Medicine New Haven CT USA

4. Yale Cancer Center New Haven CT USA

5. Department of Surgery Yale University School of Medicine New Haven CT USA

6. Department of Molecular, Cellular, and Developmental Biology Yale University New Haven CT USA

7. Department of Pathology Yale University School of Medicine New Haven CT USA

8. Yale Cancer Biology Institute Yale University West Haven CT USA

9. Hospital of Skin Diseases Chinese Academy of Medical Sciences and Peking Union Medical College Nanjing China

10. Yale Center for RNA Science and Medicine New Haven CT USA

11. Yale Cooperative Center of Excellence in Hematology New Haven CT USA